Certara
NantHealth said this week that it has launched a fully integrated genomic and transcriptomic analytic engine that can identify mutations such as copy number variants and genomic rearrangements in DNA, RNA, and protein pathways accurately and efficiently.
Certara has hired Edmundo Muniz as its CEO.
This week, Thomson Reuters launched Cortellis Data Fusion, an addition to the company's Cortellis suite, which provides access to information for drug discovery and development.
Certara said this week that Medivir, a Swedish pharmaceutical company that focuses on infectious diseases such as hepatitis C, has selected its D360 software as its global drug discovery platform.
Arsenal Capital Partners, a New York-based private equity firm, has bought Certara, a provider of model-based drug development and data analytics software and consulting services, from Vector Capital for an undisclosed sum.
Dec 19, 2013
Arsenal Capital Partners Buys Certara
Dec 13, 2013
Oct 25, 2013
Aug 16, 2013
Jun 7, 2013
Mar 22, 2013
Feb 22, 2013
Dec 7, 2012
Nov 16, 2012
Sep 7, 2012
Apr 13, 2012
Oct 29, 2010